Related references
Note: Only part of the references are listed.Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States
B. Ashleigh Guadagnolo et al.
CANCER (2013)
Use of Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer in the United States
Lia M. Halasz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype
Nils D. Arvold et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases
May Tsao et al.
CANCER (2012)
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S. Dawood et al.
ANNALS OF ONCOLOGY (2011)
Incidence of and survival following brain metastases among women with inflammatory breast cancer
S. Dawood et al.
ANNALS OF ONCOLOGY (2010)
THE EFFECT OF EARLY DETECTION OF OCCULT BRAIN METASTASES IN HER2-POSITIVE BREAST CANCER PATIENTS ON SURVIVAL AND CAUSE OF DEATH
Anna Niwinska et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Validation of the graded prognostic assessment index for patients with brain metastases
Carsten Nieder et al.
ACTA ONCOLOGICA (2009)
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Central Nervous System Metastases
Brian Leyland-Jones
JOURNAL OF CLINICAL ONCOLOGY (2009)
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
Eric L. Chang et al.
LANCET ONCOLOGY (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis
Kadri Altundag et al.
CANCER (2007)
Inflammatory breast cancer (IBC) and patterns of recurrence - Understanding the biology of a unique disease
Massimo Cristofanilli et al.
CANCER (2007)
Competing risk analysis using R: an easy guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2007)
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier
Hans-Joachim Stemmler et al.
ANTI-CANCER DRUGS (2007)
Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment
AM Gonzalez-Angulo et al.
CANCER (2004)
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival
KD Miller et al.
ANNALS OF ONCOLOGY (2003)
Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: Distinct clinicopathologic entities?
WF Anderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data
JB Choudhury
STATISTICS IN MEDICINE (2002)
Share Paper
